Generation of nervous system-specific Nptx2 KO mice

To study the role of NPTX2 in emotion related behaviors, we confirmed the expression of Nptx2 in the murine brain using ISH (Supplementary Fig. S1a–e). To develop nervous system-specific Nptx2 conditional KO mice (cKO), we generated loxP-flanked Nptx2 (Nptx2f/f) mice. We crossed Nptx2 floxed mice with Sox1::Cre mice, which specifically express Cre throughout the neural tube from E11 [18]. These tissue specific cKO mice permitted an investigation into the functions of Nptx2 in the brain. First, we demonstrated that Nptx2 expression is dramatically decreased in the hippocampus by measuring mRNA via quantitative polymerase chain reaction (qPCR) (p < 0.0001, t = 10.14, n = 8) and protein levels via western blot (p < 0.0001, t = 50.81, n = 6) (Fig. 1a). Immunohistochemistry (IHC) showed only a few NPTX2-positive cells remained in cKO mice (Fig. 1b). On the IHC stains, we notice that some mossy fiber staining can be observed in Nptx2 KO mice. Since the western and qPCR data demonstrates very low levels of this gene and protein in KO, this remaining staining should be a result of nonspecific staining. Next, by using IHC, we demonstrated that NPTX2 co-localizes with the neuronal marker NeuN, but not the glial marker GFAP (Fig. 1c). We then showed Nptx2 mRNA co-localizes with Vglut1 in the dentate gyrus (DG) and CA3 using double ISH. However, we detected minimal colocalization with Gad65/Gad67. This suggests that Nptx2 is expressed primarily in excitatory neurons of the hippocampus (Supplementary Fig. S1f–i).

Fig. 1 Generation of Nptx2 conditional knockout mice. a Nptx2 floxed mice were crossed with Sox1::Cre mice to knockout Nptx2 specifically in the brain from early development or with CAG::CreERT2 to knockout Nptx2 in adulthood. We confirmed the high knockout efficiency of Nptx2 in the hippocampus at mRNA (n = 8) and protein levels (n = 6) for both models. b Immunohistochemistry confirmed the absence of NPTX2-positive cells in both the hippocampus and amygdala. c NPTX2 co-localized with NeuN (a marker for neurons), but not GFAP (a marker for glia). Gray arrowheads indicate no colocalization. White arrowheads indicate colocalization of two markers. Scale bar represents 200 µm. Values represent mean ± SEM. ***p < 0.001 Full size image

Increased anxiety responses in Nptx2 cKO mice

To investigate the relationship between Nptx2 and anxiety, we subjected mice to a battery of behavioral tests (WT, n = 24; cKO, n = 21). This battery included the open field test, light–dark box, elevated-O-maze, and novelty-suppressed feeding. Overall, our results showed that Nptx2 deletion robustly increased anxiety-like behaviors. In the open field, cKO mice spent less time in the center zone (p < 0.001, t (43) = 3.84) with no significant difference in the total distance traveled (p = 0.11, t (43) = 1.65) (Fig. 2a). In the light–dark box, cKO mice spent less time in the white box (p = 0.001, t (43) = 3.33) and made fewer transitions between the two compartments (p < 0.0001, t (43) = 4.64) (Fig. 2b). In the elevated-O-maze, we found that cKO mice spent less time in the open arms (p = 0.001, t (43) = 3.65), but they did not exhibit a significant difference in the number of open arm entries (p = 0.63, t (43) = 0.49) (Fig. 2c). Our results indicate cKO mice express higher levels of anxiety than WT mice. To further confirm this conclusion, we conducted an activity independent anxiety test, the novelty-suppressed feeding test. This test revealed that cKO mice exhibit a longer latency to approach food pellets (p = 0.0002, t (43) = 4.18) and spend less time eating in a new environment (p = 0.008, t (43) = 2.87) (Fig. 2d). WT and cKO mice had comparable home cage food consumption (p = 0.37, t (43) = 1). Altogether, these results further demonstrate that Nptx2 plays an important role in mediating anxiety.

Fig. 2 Nptx2 knockout mice show increased anxiety. a–d Mice with brain-specific Nptx2 KO (Sox1::Cre) (WT, n = 24; cKO, n = 21) and e–h tamoxifen-induced KO (CAG::CreERT2) (WT, n = 14; iKO, n = 11) showed increased anxiety behavior. a, e In the open field, KO mice spent less time in the central zone of the open field without a significant difference in distance traveled. b, f In the light–dark box, WT mice stayed longer in the white box and made more transitions between the two boxes. c, g In the elevated-O-maze, KO mice spent less time in the open arms and made a similar number of arm entries compared with WT. d, h In the novelty-suppressed feeding test, WT mice approached food pellets faster and spent more time eating than KO mice. Values represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 Full size image

Altered hippocampal progenitor cell proliferation in Nptx2 cKO mice

Nptx2 is expressed in the dentate gyrus and is upregulated following BDNF infusion, antidepressant treatment, and exercise [1, 12]. Since these factors play a significant role in neurogenesis [19, 20], we asked whether Nptx2 contributes to the regulation of adult hippocampal neurogenesis. To investigate this, we injected mice with 5-bromo-2’-deoxyuridine (BrdU) (200 mg/kg, i.p.) to label newly born cells. Mice were killed 28 days after this BrdU injection to evaluate cell survival. We also assessed proliferation of neuronal progenitors by staining for doublecortin (DCX), a marker for immature neurons, and Ki67, a marker for cell proliferation. We demonstrated that cell proliferation and the number of immature neurons is dramatically decreased in Nptx2 cKO mice (n = 8) as measured by Ki67 (p = 0.002, t (14) = 3.75) and DCX (p < 0.0001, t (14) = 6.98) staining. However, there was no significant difference in BrdU labeled cell counts (p = 0.5) (Fig. 3a, b left). Approximately 65% of the BrdU-positive cells were also positive for the neuronal marker, NeuN; however, there were no differences in the percentage of BrdU/NeuN co-labeling between the two groups (n = 6, p = 0.58, t = 0.68). These data reveal that despite the reduction of proliferating cells in the DG in cKO mice, neurogenesis is maintained, presumably due to a higher survival rate. This may reflect a compensation effect regulated by other factors to maintain adequate overall neurogenesis. Overall, these findings suggest that mice without Nptx2 exhibit decreased progenitor cell proliferation but not altered neurogenesis.

Fig. 3 Nptx2 knockout mice exhibit aberrant hippocampal cell proliferation and increased stress-induced neuronal activity. a Images of neurogenesis markers DCX, Ki67, and BrdU in the dentate gyrus of the hippocampus. b There were significantly reduced DCX and Ki67 labeled cell counts in the cKO hippocampus, but there were no significant differences in BrdU-positive cell numbers (left, n = 8). Inducible Nptx2 KO had a similar decrease in cell proliferation (right, WT, n = 14; iKO, n = 11). c, d Images and quantification of c-Fos in the hippocampus DG, CA1, and CA3. Brain-specific KO (left, n = 8) and inducible KO mice (right, WT, n = 14; iKO, n = 11) have higher levels of c-Fos-positive cells in DG and CA3, but not in CA1 after acute restraint stress. Scale bar represents 200 µm. Values represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 Full size image

Altered stress-induced neuronal activity in Nptx2 cKO mice

Altered plasma cortisol and stress-induced dysfunction through the hypothalamic–pituitary–adrenal (HPA) axis are important features in anxiety disorders [21]. To further investigate the role of Nptx2 in response to stress, we measured plasma corticosterone levels at basal conditions and after 30 and 90 min after 30 min restraint stress. We found that corticosterone levels are higher in Nptx2 cKO mice (n = 7) at the 30-min time point (p = 0.007, t (12) = 3.23), but there were no significant differences at either the basal (p = 0.24, t (12) = 1.24) nor 90-min time point (p = 0.19, t (12) = 1.36) (Supplementary Fig. S2a). These results demonstrate that Nptx2 cKO mice exhibit a greater HPA response to stress.

We then predicted that our observed differences in stress responsivity would manifest in concomitant neural activity measures in the hippocampus. c-Fos, an immediate early gene, is commonly used as a neuronal activity marker following a stimulus [22]. To characterize neuronal activity in WT and cKO hippocampi in response to stress (n = 8), we measured neuronal activation by quantifying the number of c-Fos-positive cells 90 min after 30 min of restraint stress in both WT and cKO mice. Interestingly, cKO mice showed more c-Fos-positive cells in the DG (p = 0.018, t (14) = 2.68) and CA3 (p = 0.021, t (14) = 2.61), but not in CA1 (p = 0.5, t (14) = 0.68) and amygdala (p = 0.18, t (14) = 1.41) (Fig. 3c, d left, Supplementary Fig. S3), suggesting Nptx2 null mice display increased hippocampal neuronal activity in response to stress.

The increased anxiety responses and altered hippocampal cell proliferation in Nptx2 KO mice are not due to abnormal brain development

To determine whether the abnormal behaviors we observed in Nptx2 cKO mice was a consequence of Nptx2 inactivation during early embryonic development, we crossed Nptx2 floxed mice with CAG::CreERT2 mice to induce loss of Nptx2 specifically in adulthood upon tamoxifen administration (WT: Nptx2f/f; iKO: Nptx2f/f– CAG::CreERT2). Fourteen days after three daily injections of tamoxifen (100 mg/kg, i.p.), we assayed all mice using our behavioral battery described above (WT, n = 14; iKO, n = 11). In the open field, Nptx2 iKO mice spent less time in the center zone (p = 0.02, t (23) = 2.47) with no significant difference in the total distance traveled (p = 0.64, t (23) = 0.46) (Fig. 2e). In the light–dark box test, iKO mice spent less time in the light compartment (p = 0.012, t (23) = 2.7) with no significant differences in the number of transitions between the two boxes (p = 0.54, t (23) = 0.61) (Fig. 2f). In the elevated-O-maze, iKO mice spent less time in the open arms (p = 0.004, t (23) = 3.5) and made fewer entries into the open arms (p = 0.023, t (23) = 2.57) (Fig. 2g). Finally, iKO mice showed a longer latency to approach food pellets (p = 0.011, t (23) = 2.79) and spent less time eating (p = 0.01, t (23) = 2.89) (Fig. 2h) in the novelty-suppressed feeding test. We also found no significant differences in home cage food consumption between WT and iKO mice (p = 0.15, t (23) = 2.3). We assayed both Nptx2 mRNA and protein levels in these mice (qPCR: p = 0.0002, t = 13.28, n = 8; Western blot: p = 0.0001, t = 4.81, n = 6). IHC analysis confirms there were significantly fewer NPTX2-positive cells in the hippocampus and amygdala in Nptx2 iKO after tamoxifen injection (Fig. 1a, b).

We further analyzed hippocampal neurogenesis in these Nptx2 inducible KO mice (WT, n = 14; iKO, n = 11). We found mice with induced Nptx2 deletion display exhibit fewer DCX (p < 0.0001, t (23) = 5.39) and Ki67 (p = 0.01, t (23) = 2.8) positive cells in the DG, but no significant differences in BrdU-positive cells (p = 0.76, t (23) = 0.31) (Fig. 3b right). However, induced Nptx2 deletion yielded no significant differences in the plasma corticosterone level at any time after restraint stress (WT, n = 14; iKO, n = 11) (Supplementary Fig. S4b). Inducible KO mice exhibited greater c-Fos-positive cells in the DG (p < 0.0001, t (23) = 5.06) and CA3 (p < 0.0001, t (23) = 5.21), but not CA1 (p = 0.5, t (23) = 0.69) and amygdala (p = 0.085, t (23) = 1.81), 90 min following 30 min of restraint stress (Fig. 3d right and Supplementary Fig. S3). These data suggest that the altered anxiety and progenitor cell proliferation can occur as a consequence of Nptx2 inactivation in adulthood, and not only because of developmental defects. Furthermore, we demonstrate that these changes in anxiety when the gene is deleted in adulthood are not due to corticosterone overproduction after stress.

Hippocampus-specific knockout of Nptx2 is sufficient to increase anxiety responses

Since chronic antidepressant treatment or exercise upregulates Nptx2 expression in the hippocampus [1, 13] and Nptx2-deficient mice display more c-Fos-positive cells in the DG and CA3 regions but not the amygdala after acute stress, we hypothesized that hippocampal Nptx2 modulates anxiety behavior. To answer this, we injected either AAV-Cre or AAV-eGFP viral vectors into both the dorsal and ventral hippocampus in Nptx2f/f mice (n = 10). Fourteen days after surgery, we assayed mice in our behavioral battery: open field, light–dark box, elevated-O-maze, and novelty-suppressed feeding tests. Our results show that Nptx2f/f mice injected with AAV-Cre (Nptx2f/f-Cre) showed increased anxiety compared to the injected control AAV-eGFP group (open field: distance, p = 0.17, t (18) = 1.4; time in center zone, p = 0.04, t (18) = 2.21; light–dark box: time in white box, p < 0.0001, t (18) = 5.06; transitions, p = 0.03, t (18) = 2.24; elevated-O-maze: time in open arms, p = 0.005, t (18) = 3.31; open arms entries, p = 0.003, t (18) = 3.45; novelty-suppressed feeding: first latency, p = 0.03, t (18) = 2.27; time spent on eating, p = 0.01, t (18) = 2.77; food consumption, p = 0.32, t (18) = 1.3) (Fig. 4a). These results are consistent with our data from cKO and iKO animal models.

Fig. 4 Hippocampal Nptx2 knockdown by AAV-Cre injection causes increased anxiety. a Mice injected with AAV-Cre virus featured significantly increased anxiety. This is demonstrated by a decrease in time spent in the central zone (open field), less time spent in the open arms and fewer entries to the open arms (elevated-O-maze), spent less time in and made less transition to the white box (light–dark box), exhibited a greater latency to approach food pellets and spent less time eating (novelty-suppressed feeding test) compared to mice with AAV-eGFP virus injection (n = 10). b, c Viral vector expression (eGFP) and antibody staining of NPTX2 in the dorsal and ventral hippocampus. Immunohistochemistry confirmed there were no NPTX2-positive cells in the hippocampus. d mRNA expression of Nptx2 and NPTX2-positive cell number in the hippocampus (n = 6). Scale bar represents 500 µm. Values represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 Full size image

Next, we subjected these mice to acute restraint stress and collected plasma after 30 minutes to assay corticosterone level. We found no significant differences in stress-induced plasma corticosterone levels between the two groups (p = 0.73, t = 0.35, n = 8) (Supplementary Fig. S2c). These results suggest that hippocampal Nptx2 does not alter stress-induced corticosterone release. After harvesting the hippocampal tissue, we confirmed local inactivation of hippocampal Nptx2 in this cohort of mice measured by two assays (qPCR, p = 0.0003, t = 6.19; IHC, p = 0.008, t = 10.58, n = 6) (Fig. 4b–d).

The amygdala plays a crucial role in fear and anxiety [23]. Since Nptx2 is expressed in amygdala, we examined the contribution of amygdala Nptx2 in anxiety via injecting AAV-Cre or AAV-eGFP viral vectors into the amygdala in Nptx2f/f mice (n = 8). Fourteen days after surgery, we assayed mice in the behavioral battery described above. Our results showed no significant differences between amygdala Nptx2 knockout and controls in the open field test (distance p = 0.49, t (14) = 0.7; time in center zone p = 0.47, t (14) = 0.75), light–dark box (time in white box p = 0.63, t (14) = 0.5; transition p = 0.21, t (14) = 1.3), elevated-O-maze (time in open arms p = 0.46, t (14) = 0.77; open arms entries p = 0.45, t (14) = 0.77). For the novelty-suppressed feeding test, the amygdala Nptx2 knockout mice spent more time eating, but we found no significant differences in first latency and food consumption (first latency p = 0.65, t (14) = 0.47; time spent eating p = 0.0001, t(14) = 5.2; food consumption p = 0.52, t (14) = 0.65) (Supplementary Fig. S4d–g). We confirmed local inactivation of amygdala Nptx2 in these mice as measured by IHC (p < 0.0001, t (14) = 7.25) (Supplementary Figure S4a–c). Altogether, these data suggest that Nptx2 expression in the hippocampus, but not the amygdala, plays a critical role in anxiety-related behaviors.

Nptx2 modulates hippocampal corticotropin-releasing hormone and glucocorticoid-related pathways

To determine the mechanism through which Nptx2 alters anxiety, we assessed differences in hippocampal gene expression between brain-specific Nptx2 cKO and WT mice by RNA-sequencing (RNAseq; n = 3). We found 397 genes with differential expression. Of these, we selected 53 genes (p < 0.05, fold change > 1.5 or <−1.5), excluding genes with low expression (expression value > 0.1) (Supplementary Fig. S5). Among these candidate genes, we found that corticotropin-releasing hormone (Crh) was strongly upregulated (p = 0.00038, fold change = 1.69).

Hippocampal Crh, mineralcorticoid receptor (MR), glucocorticoid receptor (GR), and GR downstream genes play important roles in anxiety [24,25,26,27]. We examined whether Nptx2 alters the expression of Crh and glucocorticoid-related genes by assaying the differences in hippocampal gene expression between Nptx2 WT and cKO mice (n = 8). First, we confirmed increased expression of hippocampal Crh in Nptx2 cKO mice (p = 0.001, t (14) = 3.82) (Fig. 5a). Using IHC, we demonstrated that NPTX2 co-localizes with corticotropin-releasing hormone receptor 1 (CRHR1), but not CRH containing neurons (Supplementary Fig. S1l-o). Since Nptx2 alters the expression of hippocampal Crh, we investigated the expression of glucocorticoid signaling related genes in the hippocampus, including Nr3c1 (GR), Nr3c2 (MR), Crhr1, Sgk1, Fkbp5, and Gilz. We found that Nptx2 cKO mice exhibit higher levels of MR (p = 0.0018, t (14) = 3.82) and Crhr1 (p = 0.005, t (14) = 3.36), but we found no significant differences in GR downstream genes (Fig. 5a). For tamoxifen-induced Nptx2 deletion mice (n = 8), we confirmed upregulated Crh in Nptx2 iKO mice (p = 0.02, t (14) = 2.55). There were no differences in MR, Crhr1, and GR downstream gene expression (Fig. 5b).

Fig. 5 Nptx2 regulates corticotrophin releasing hormone (Crh) and glucocorticoid pathway gene expression. a, b Expression of glucocorticoid-related genes (Crh, GR, MR, Crhr1, Sgk1, Fkbp5, and Gilz) in the hippocampus of Nptx2 KO mice (brain-specific and tamoxifen-induced) (n = 8). c, d Gene expression in the hippocampus after 90 min of initiating 30 min of restraint stress in brain-specific KO or tamoxifen-induced KO mice (n = 8). e Gene expression in the hippocampus of control-eGFP and AAV-Cre injected mice after acute restraint stress (n = 6). f Gene expression of the hippocampus of WT and cKO mice 90 minutes after a single corticosterone injection (2.5 mg/kg, i.p. n = 8). Values represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 Full size image

Interactions between genetic predisposition and environment play an important role in the development of psychiatric disorders. To determine whether Nptx2 alters the expression of glucocorticoid signaling related genes after stress, Nptx2 WT and cKO mice (n = 8) experienced restraint stress for 30 min and were sacrificed after 90 min. We detected several gene expression changes in the hippocampus of cKO mice following acute stress, including upregulation of Crh (p = 0.03, t (14) = 2.37), GR (p = 0.01, t (14) = 2.89) and GR downstream genes, such as Sgk1 (p = 0.01, t (14) = 2.83), and Fkbp5 (p = 0.02, t (14) = 2.51) (Fig. 5c). We also detected similar changes in inducible Nptx2 knockout mice (iKO; Crh p = 0.005, t (14) = 3.68, GR p = 0.01, t (14) = 3.01, Crhr1 p = 0.01, t (14) = 3.17, Fkbp5 p = 0.003, t (14) = 3.89) and Nptx2 floxed mice injected with AAV-Cre into the hippocampus (Nptx2f/f –Cre, n = 6; Crh p = 0.002, t (14) = 4.47, GR p = 0.004, t (14) = 3.68, Sgk1 p = 0.009, t (14) = 3.31, Fkbp5 p = 0.0003, t (14) = 5.32, Gilz p = 0.018, t (14) = 2.83) (Fig. 5d, e). These results suggest Nptx2 influences GR, Sgk1, and Fkbp5 expression during stress.

Since stress increases plasma corticosterone, we wanted to determine whether the expression of these GR-related genes in Nptx2-deficient mice respond differently to elevated plasma corticosterone. We injected both WT and cKO mice (n = 8) with a single dose of corticosterone (CORT, 2.5 mg/kg, i.p.) to imitate the adrenal hormone stress response. We detected no significant differences in plasma corticosterone between WT and cKO mice 90 min after injection (WT 582.7 ± 44.71 ng/ml; KO 590.6 ± 56.94 ng/ml, p = 0.91, t (14) = 0.1). Interestingly, cKO mice exhibited higher expression of Crh (p = 0.003, t (14) = 3.6), GR (p = 0.04, t (14) = 2.16), Crhr1 (p = 0.019, t (14) = 2.65), Sgk1 (p = 0.04, t (14) = 2.26) and Fkbp5 (p = 0.0007, t (14) = 4.54) (Fig. 5f). These results suggest that NPTX2 regulates sensitivity of GR signaling, rather than corticosterone levels per se.

Overexpression of Nptx2 in the hippocampus reduces stress-induced anxiety

To study the potential of Nptx2 to be a target for novel treatments for anxiety, we overexpressed Nptx2 in the hippocampus. C57BL/6 mice were separated into two groups (n = 10) and injected with either AAV-CB (chicken-beta actin)-Nptx2 viral vector (OE) or with an AAV-CB-eGFP viral vector (Control) into the hippocampus. Fourteen days after surgery, we subjected all mice to behavioral testing. Our results showed no significant differences between OE mice and controls in the open field test, light–dark box, elevated-O-maze, novelty-suppressed feeding (Supplementary Fig. S6). Hippocampal tissues were harvested and we detected a robust increase in Nptx2 mRNA expression in AAV-CB-Nptx2 viral vector injecting group compared to eGFP control (p = 0.002, t = 3.79. n = 8). These results show that increased hippocampal Nptx2 expression does not alter anxiety.

Because C57BL/6 is one of the least anxious inbred mouse strains [28], we tested whether increased Nptx2 can reduce anxiety following stress. Fourteen days after injection of overexpression or control viral vector into the hippocampus (C57BL/6 mice, n = 10), all mice were subjected to 3 h of restraint stress. We initiated behavioral tests following 6 h of post-stress resting in the home cage. We found that Nptx2 overexpressing mice exhibit less anxious behavior in all four tests compared to eGFP control mice (open field: distance p = 0.47, t (18) = 0.73, time in center zone p = 0.01, t (18) = 2.83; light–dark box: time in white box p = 0.01, t (18) = 2.83, transitions p = 0.22, t (18) = 1.25; elevated-O-maze: time in open arms p = 0.0.02, t (18) = 2.57; open arms entries p = 0.24, t (18) = 1.2; novelty-suppressed feeding: first latency p = 0.008, t (18) = 2.93; time spent on eating p = 0.07, t (18) = 1.89) (Fig. 6a–d). This suggests increased Nptx2 is protective against stress-induced anxiety.

Fig. 6 Overexpression of Nptx2 alleviates stress-induced anxiety and reverses the expression of stress-related genes. a–d Hippocampal Nptx2 overexpression alleviated stress-induced anxiety (n = 10). e Immunohistochemistry demonstrated an increase in NPTX2-positive cells in the hippocampus of Nptx2 overexpression mice. f qPCR confirmed increased mRNA expression of Nptx2 in the hippocampus (n = 7). g, h Cell numbers of NPTX2 in DG and CA3 measured by Immunohistochemistry (n = 6). i The expression of glucocorticoid-related genes in the hippocampus of control and Nptx2 overexpression mice after acute stress (n = 7). Scale bar represents 200 µm. Values represent mean ± SEM. *p < 0.05, **p < 0.01, ***p < 0.001 Full size image

We then sacrificed these mice 90 min following 30 min of restraint stress and assayed plasma corticosterone. We found no significant differences in plasma corticosterone levels between OE and control mice (p = 0.4, t = 0.86, n = 8) (Supplementary Fig. S2d). After measuring Nptx2 expression levels, we confirmed that mice injected with AAV-CB-Nptx2 viral vector expressed higher levels of Nptx2 mRNA (p < 0.0001, t = 6.17; n = 7) (Fig. 6f). We also confirmed that Nptx2 overexpressing mice had more NPTX2-positive cells (DG p = 0.0002, t = 5.86; CA3 p < 0.0001, t = 18, n = 6) (Fig. 6e, g, h). After stress, Nptx2 overexpressing mice exhibited reduced expression of Crhr1, Sgk1, and Fkbp5 (Crhr1 p = 0.02, t = 2.68, Sgk1 p = 0.03, t = 2.42, Fkbp5 p = 0.04, t = 2.3; n = 7) (Fig. 6i). Intriguingly, among these GR-related genes, Fkbp5 expression coincides with Nptx2 present (knockout and overexpression) under stress condition. Double ISH showed that Nptx2 co-localized with Fkbp5 in the DG and CA3 (Supplementary Fig. S1j, k). Overall, these results indicate that increased Nptx2 reverses stress-induced behavioral changes and decreases GR downstream gene expression.